Word

REPLICATE

Status

Pending

Status Code

731

Status Date

Thursday, March 28, 2024

Serial Number

97157972

Mark Type

4000

Filing Date

Monday, December 6, 2021

Published for Opposition

Tuesday, March 21, 2023

Trademark Owner History

Replicate Bioscience, Inc. - Owner At Publication

Classifications

5 Pharmaceutical and biologic preparations for the treatment of cancer, autoimmune disorders and diseases, inflammatory disorders and diseases, and infectious disorders and diseases; Biological compounds being a component in vaccines; Therapeutic agents and immunotherapies for the treatment of cancer, autoimmune diseases, inflammatory diseases, and infectious diseases; Biological compound for medical use, namely, self-replicating RNAs delivered into patient cells for creating therapeutic proteins; Therapeutic agents for generating or evading protective immune response

42 Research and development services in the fields of self-replicating RNAs, RNA therapeutics, pharmaceuticals, biologics, therapeutic proteins, cancer, autoimmune diseases, inflammatory diseases, and infectious diseases; Providing medical scientific information in the fields of self-replicating RNAs, RNA therapeutics, pharmaceuticals, biologics, therapeutic proteins, cancer, autoimmune diseases, inflammatory diseases, and infectious diseases

Trademark Events

Mar 29, 2024

Notice Of Approval Of Extension Request E-Mailed

Mar 28, 2024

Sou Extension 2 Granted

Mar 28, 2024

Sou Extension 2 Filed

Mar 28, 2024

Sou Teas Extension Received

May 23, 2023

Notice Of Approval Of Extension Request E-Mailed

May 20, 2023

Sou Extension 1 Granted

May 20, 2023

Sou Extension 1 Filed

May 20, 2023

Sou Teas Extension Received

May 16, 2023

Noa E-Mailed - Sou Required From Applicant

Mar 21, 2023

Official Gazette Publication Confirmation E-Mailed

Mar 21, 2023

Published For Opposition

Mar 1, 2023

Notification Of Notice Of Publication E-Mailed

Feb 10, 2023

Approved For Pub - Principal Register

Jan 13, 2023

Teas/Email Correspondence Entered

Jan 12, 2023

Correspondence Received In Law Office

Jan 12, 2023

Teas Response To Office Action Received

Sep 26, 2022

Notification Of Non-Final Action E-Mailed

Sep 26, 2022

Non-Final Action E-Mailed

Sep 26, 2022

Non-Final Action Written

Sep 14, 2022

Assigned To Examiner

Dec 10, 2021

New Application Office Supplied Data Entered

Dec 9, 2021

New Application Entered